A ventricular drain (or ventricular stent) is a surgically placed opening device that is used in the inner chamber of the heart to remove surplus fluids, usually to relieve arterial blockage caused by narrowed arteries. Such an opening device can either be internal or external – with the latter being placed externally (outside the heart). Although the concept sounds simple enough, it has proved very effective in various situations. Ventricular drainage sets are widely used in the treatment of various types of diseases including intraventricular hemorrhage, neurological disorders, and many more. As per the Alzheimer Association, in 2021, around 6.2 million people in the U.S. aged 65 years and above are living with Alzheimer’s dementia. As per the National Organization for Rare Disorders (NORD), around 25 to 35 in 100,000 people in the U.S. are affected by Bell’s palsy, while 40,000 individuals are diagnosed with the same in the U.S. each year. External ventricular drain (EVD) is one the most common and important lifesaving procedures in neurologic intensive care unit. Hence, such factors can augment growth of the ventricular drainage sets market.
Over the years, the demand for ventricular drainage sets has increased in the U.S. since there has been increased cases of hospitalization due to traumatic brain injury. Such high demand can potentially stimulate the regional ventricular drainage sets market in the near future. Asia Pacific seems to be exhibiting positive signs for the adoption of these devices due to high prevalence of neurological diseases in the region. Recently, in December 2019, Raumedic AG, a German medical devices manufacturer, launched Raumed Home ICP for intracranial pressure (ICP) monitoring.
Read More : https://bit.ly/3gz5Rtu
